Cancer screening guidelines and prevention factors for high-risk patients with a family history of colorectal cancer
Current Colorectal Cancer Reports, ISSN: 1556-3790, Vol: 1, Issue: 2, Page: 110-116
2005
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Family history of colorectal cancer or of adenomas may confer significant risk of colorectal cancer. Ideally, diagnosis of an inherited syndrome such as familial adenomatous polyposis (FAP) or hereditary nonpolyposis colorectal cancer (HNPCC) enables a molecular biology-driven approach to screening and management. When no hereditary syndrome can be established, clinicians must rely on empiric risk estimates and offer screening accordingly. Detailed rationale and guidelines for use of syndrome characteristics including genetic testing, counseling, and selection of surveillance tools are discussed. Copyright © 2005 by Current Science Inc.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84873393943&origin=inward; http://dx.doi.org/10.1007/s11888-005-0007-2; http://link.springer.com/10.1007/s11888-005-0007-2; http://link.springer.com/content/pdf/10.1007/s11888-005-0007-2; http://link.springer.com/content/pdf/10.1007/s11888-005-0007-2.pdf; http://link.springer.com/article/10.1007/s11888-005-0007-2/fulltext.html; http://www.springerlink.com/index/10.1007/s11888-005-0007-2; http://www.springerlink.com/index/pdf/10.1007/s11888-005-0007-2; https://dx.doi.org/10.1007/s11888-005-0007-2; https://link.springer.com/article/10.1007/s11888-005-0007-2
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know